United States Neurovascular Embolization Devices Market Assessment, By Product [Aneurysm Clips, Liquid Embolic Systems, Embolization Coils, Flow Diversion Stents, Intravascular Flow Disruptors], By Disease Pathology [Ischemic Strokes, Cerebral Aneurysm, Carotid Artery Stenosis, Arteriovenous Malformations and Fistulas, Other Diseases], By End Use [Hospitals, Ambulatory Surgical Centres, Specialty Clinics, Others], By Region, Opportunities, and Forecast, 2016-2030F

The United States Neurovascular Embolization Devices market was valued at 328 million in 2022 and is projected to be growing at a CAGR of 8.51% from 2023 to 2030.

Home>Industry Reports>United States Neurovascular Embolization Devices Market Assessment, Opportunities, and Forecast, 2016-2030F

Improved access to healthcare services and insurance coverage in the United States have resulted in a more robust infrastructure for treatment of neurovascular patients. The United States Neurovascular Embolization Devices market was valued at 328 million in 2022 and is projected to be growing at a CAGR of 8.51% from 2023 to 2030. The increasing prevalence of haemorrhages & anomalies in cerebral arteries, rising cases of brain aneurysms, and arteriovenous malformations (AVMs) due to sedentary lifestyles are the main causes of surge in demand for neurovascular embolization devices. In addition, factors driving the growth of the United States neurovascular embolization devices market includes increasing geriatric population, increasing number of patients with hypertension and the introduction of novel neurovascular embolization devices.

An intravascular implant called a neurovascular embolization device is designed to permanently cut off blood supply to brain aneurysms and arteriovenous malformations.

Increasing Number of Patients with Cerebral Aneurysm

In recent years, there has been an increasing number of cerebral aneurysm patients in the United States, which has led to a growing demand for neurovascular embolization devices in the market. The market for these devices has been growing as more patients are diagnosed with cerebral aneurysms and seek treatment. Ruptured brain aneurysm affects around 6.7 million people in the United States, or one in every fifty people. Women above the age 55, have a higher risk of cerebral aneurysm rupture as compared to men.

Technological Advancements

Technological advancements have made it possible to identify a size and shape of aneurysm. One major advancement is the development of new materials for embolization coils and flow diverters. These devices are used to block blood flow to abnormal blood vessels in the brain, and the new materials provide better visibility and control during the procedure. Additionally, there has been increased use of robotic systems for neurovascular procedures, which provide greater precision and control during the procedure.

Cerebral Embolization and Aneurysm Coiling Devices Account for Majority of Market Share

Cerebral embolization and aneurysm coiling devices led the neurovascular device market. More than 40% of the market was accounted for cerebral embolization and aneurysm coiling devices, which are widely used in the treatment of aneurysms and strokes. Rising healthcare costs, increased R&D spending, and rising frequency of neurological diseases such as brain aneurysms, stroke, and arteriovenous malformations (AVMs) are few factors driving the market expansion.

Impact of COVID-19 on the United States Neurovascular Embolization Devices Market

The pandemic had a significant impact on the United States Neurovascular Embolization Device Market. The market has witnessed a decline in growth due to the pandemic's impact on healthcare facilities' operations, as well as a reduction in demand for non-urgent medical procedures. Additionally, the disruption of supply chains caused by the pandemic has led to delays in the production and distribution of neurovascular embolization devices, further impacting the market's growth. The market bounced back to pre-pandemic levels after upliftment of lockdown.

Impact of Russia-Ukraine War on the United States Neurovascular Embolization Devices Market

The Russia-Ukraine war did not have a significant impact on the United States neurovascular embolization market. Although, the war disrupted the trade dynamics such as demand-supply, pricing variances, impact on import/export and trading activities between United States, Russia, and Ukraine. Economic sanctions imposed by United States impacted the export of devices to Russia.

United States Neurovascular Embolization Devices Market Assessment, Opportunities, and Forecast, 2016-2030F: Report Scope

United States Neurovascular Embolization Devices Market Assessment, Opportunities, and Forecast, 2016-2030F”, is a comprehensive report by Market Xcel, providing in-depth analysis and assessment of the current situation of the neurovascular embolization devices market in the United States, industry dynamics and challenges. The report includes market size, segmental shares, growth trends, impact of COVID-19 and impact of Russia-Ukraine war, opportunities, and forecasts (2023-2030). Additionally, the report profiles the leading players in the industry mentioning their respective market share, business model, competitive intelligence, etc.

Report Attribute

Details

Base Year of the Analysis

2022

Historical Period

2016-2021

Forecast Period

2023-2030

Projected Growth Rate

CAGR of 8.51% from 2023-2030

Revenue Forecast in 2030

USD XX Billion

Units

Revenue in USD Billion and Volume in Units Thousands

Segments Covered

Product,

Disease Pathology

End User

Regions Covered

Northeast

Southwest

West

Southeast

Midwest

Key Companies Profiled

Microport Scientific Corporation, Integra LifeSciences Corporation, Medtronic Plc, Terumo Corporation (MicroVention, Inc), B. Braun Melsungen AG, Penumbra, Inc, Stryker Corporation, Kaneka Medical Products, Codman & Shrutleff, Inc, Johnson & Johnson (Cerenovous)

Customization Scope

15% free report customization with purchase

Pricing and Purchase Options

Avail the customized purchase options to fulfil your precise research needs

Delivery Format

PDF and Excel through Email (We can also provide the editable version of the report in PPT/PDF format on special request)

 

In this report, the United States Neurovascular Embolization Devices Market has been segmented into the following categories: 

1.       United States Neurovascular Embolization Devices Market, By Product

1.1.    Aneurysm Clips

1.2.    Liquid Embolic Systems

1.3.    Embolization Coils

1.4.    Flow Diversion Stents

1.5.    Intrasaccular Flow Disruptors

2.        United States Neurovascular Embolization Devices Market, By Disease Pathology

2.1.    Ischemic Strokes

2.2.    Cerebral Aneurysm

2.3.    Carotid Artery Stenosis

2.4.    Arteriovenous Malformations and Fistulas

3.       United States Neurovascular Embolization Devices Market, By End Use

3.1.    Hospitals

3.2.    Ambulatory Surgical Centers

3.3.    Specialty Clinics

3.4.    Others

4.       United States Neurovascular Embolization Devices Market, By Region

4.1.    Northeast

4.2.    Southwest

4.3.    West

4.4.    Southeast

4.5.    Midwest

Key Players Landscape and Outlook

The market for neurovascular devices is competitive and is dominated by major players. The key players in the market are Terumo Corporation, Johnson & Johnson, and Medtronic Plc, Microport Scientific Corporation, Integra Life Sciences Corporation, Penumbra Inc and many others.

In 2021, Medtronic recalled two of its transcatheter devices intended to seal brain aneurysms: the Pipeline Flex Embolization Device and the Pipeline Flex Embolization Device with Shield Technology. The wire and tubes fractured and broke down when the delivery systems were used to place, remove, or relocate the stent within a patient.

Market Xcel’s reports answer the following questions:

 

·         What is the current and future market size of the product/service in question globally or specific to different countries?

·         How are the markets divided into different product/service segments and the market size and growth of each segment?

·         What is the market potential of different product segments and their invest case?

·         How are the markets predicted to develop in the future and what factors will drive or inhibit growth?

·         What is the business environment and regulatory landscape specific to the product/service?

 

Key Players Operating in the United States Neurovascular Embolization Devices Market

·         Microport Scientific Corporation

·         Integra Life Sciences Corporation

·         Medtronic Plc

·         Terumo Corporation (MicroVention, Inc)

·         B. Braun Melsungen AG

·         Penumbra, Inc

·         Stryker Corporation

·         Kaneka Medical Products

·         Codman & Shrutleff, Inc

·         Johnson & Johnson (Cerenovous)

If you can't find what you're searching for or have any custom requirements for the United States Neurovascular Embolization Market, you may approach our team at info@marketsandata.com

Table of Contents

 

1.       Research Methodology

2.       Project Scope & Definitions

3.       Impact of Covid-19

4.       Impact of Russia-Ukraine War Market

5.       Executive Summary

6.       United States Neurovascular Embolization Devices Market Outlook, 2016-2030F

6.1.    Market Size & Forecast

6.1.1.By Value

6.1.2.By Volume

6.2.    Market Share & Forecast

6.2.1. By Product

6.2.1.1.  Aneurysm Clips

6.2.1.2.  Liquid Embolic Systems

6.2.1.3.  Embolization Coils

6.2.1.4.  Flow Diversion Stents

6.2.1.5.  Intrasaccular Flow Disruptors

6.2.2. By Disease Pathology

6.2.2.1.  Ischemic Strokes

6.2.2.2.  Cerebral Aneurysm

6.2.2.3.  Carotid Artery Stenosis

6.2.2.4.  Arteriovenous Malformations and fistulas

6.2.2.5.  Other Diseases

6.2.3.By End User

6.2.3.1.  Hospitals

6.2.3.2.  Ambulatory Surgical Centers

6.2.3.3.  Specialty Clinics

6.2.3.4.  Others

6.2.4.Region

6.2.4.1.  Northeast

6.2.4.2.  Southwest

6.2.4.3.  West

6.2.4.4.  Southeast

6.2.4.5.  Midwest

6.2.5. By Company Market Share (%), 2022

7.       Market Mapping, 2022

7.1.    By Product

7.2.    By Disease Pathology

7.3.    By End User

7.4.    By Region

8.       Macro Environment and Industry Structure

8.1.    Supply Demand Analysis

8.2.    Import Export Analysis

8.3.    Value Chain Analysis

8.4.    PESTEL Analysis of the Neurovascular Embolization Devices Market

8.4.1.Political Factors

8.4.2.Economic System

8.4.3.Social Implications

8.4.4.Technological Advancements

8.4.5.Environmental Impacts

8.4.6.Legal Compliances and Regulatory Policies (Statutory Bodies Included)

8.5.    Porter’s Five Forces Analysis

8.5.1.Supplier Power

8.5.2.Buyer Power

8.5.3.Substitution Threat

8.5.4.Threat from New Entrant

8.5.5.Competitive Rivalry

9.       Market Dynamics

9.1.    Growth Drivers

9.2.    Growth Inhibitors

10.   Regulatory Framework and Innovation

10.1.          Clinical Trials

10.2.          Patent Landscape

10.3.          FDA Approvals

10.4.          Product Innovations/Emerging Technologies 

11.   Case Studies

12.   Pricing Analysis

13.   Key Players Landscape

13.1.          Competition Matrix of Top Five Market Leaders

13.2.          Market Revenue Analysis of Top Five Market Leaders (in %, 2022)

13.3.          Mergers and Acquisitions/Joint Ventures (If Applicable)

13.4.          SWOT Analysis (For Five Market Players)

14.   Key Players Outlook

14.1.          Microport Scientific Corporation

14.1.1.                Company Details

14.1.2.                Key Management Personnel

14.1.3.                Products & Services

14.1.4.                Financials (As reported)

14.1.5.                Key Market Focus & Geographical Presence

14.1.6.                Recent Developments

14.2.          Integra LifeSciences Corporation

14.3.          Medtronic Plc

14.4.          Terumo Corporation (MicroVention, Inc)

14.5.          B. Braun Melsungen AG

14.6.          Penumbra, Inc

14.7.          Stryker Corporation

14.8.          Kaneka Medical Products

14.9.          Johnson & Johnson (Cerenovous)

14.10.      Codman & Shrutleff, Inc.

*Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work

14.   Strategic Recommendations

15.   About Us & Disclaimer

List of Figure_United States Neurovascular Embolization Devices Market

 

Figure 1. United States Neurovascular Embolization Devices Market, By Value, In USD Million, 2016 - 2030F

Figure 2. United States Neurovascular Embolization Devices Market, By Volume, In Thousand Units, 2016 - 2030F

Figure 3. United States Neurovascular Embolization Devices Market Share, By Product, In USD Million, 2016 - 2030F

Figure 4. United States Neurovascular Embolization Devices Market Share, By Product, In Thousand Units, 2016 - 2030F

Figure 5. United States Neurovascular Embolization Devices Market Share, By Disease Pathology, In USD Million, 2016 - 2030F

Figure 6. United States Neurovascular Embolization Devices Market Share, By Disease Pathology, In Thousand Units, 2016 - 2030F

Figure 7. United States Neurovascular Embolization Devices Market Share, By End User, In USD Million, 2016 - 2030F

Figure 8. United States Neurovascular Embolization Devices Market Share, By End User, In Thousand Units, 2016 - 2030F

Figure 9. United States Neurovascular Embolization Devices Market Share, By Region, In USD Million, 2016 - 2030F

Figure 10. United States Neurovascular Embolization Devices Market Share, By Region, In Thousand Units, 2016 - 2030F

Figure 11. By Product Map-Market Size (USD Million) & Growth Rate (%), 2022

Figure 12. By Disease Pathology Map-Market Size (USD Million) & Growth Rate (%), 2022

Figure 13. By End User Map-Market Size (USD Million) & Growth Rate (%), 2022

Figure 14. By Region Map-Market Size (USD Million) & Growth Rate (%), 2022

List of Table_United States Neurovascular Embolization Devices Market

Table 1. Pricing Analysis of Products from Key Players

Table 2. Competition Matrix of Top 5 Market Leaders

Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)

Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

What is the growth rate of United States Neurovascular Embolization Devices Market?

arrowup
Heart

Japan Artificial Intelligence Market Assessment, Opportunities, and Forecast, FY2017-FY2031F

Japan's Artificial Intelligence market has been witnessing notable progress. The Japan Artificial Intelligence market is estimated to achieve a value of USD 15.84 billion by the fiscal year 2031, showing substantial growth from USD 5.95 billion in FY....Read More

Published on

December 2023

3,300

Heart

Vietnam Commercial Vehicle Market Assessment, Opportunities and Forecast, 2016-2030F

Vietnam Commercial Vehicle Market size was valued at USD 3.07 billion in 2022 which is expected to reach USD 5.84 billion in 2030 with a CAGR of 8.37% for the forecast period between 2023 and 2030. ....Read More

Published on

December 2023

3,300

Heart

Japan Internet of Things Market Assessment, Opportunities and Forecast, FY2017-FY2031

Japan Internet of Things Market size is valued at USD 11.71 billion in FY2023, expected to reach USD 50.08 billion in FY2031 with a CAGR of 19.92% for the forecast period between FY2024 and FY2031.....Read More

Published on

December 2023

3,300

Heart

Japan Ready-To-Eat Food Market Assessment, Opportunities, and Forecast, FY2017-FY2031F

Japan Ready-To-Eat Food Market is expected to witness a CAGR of 4.03% during the forecast period FY2024-FY2031. The market was valued at USD 8.14 billion in FY2023 and is anticipated to reach USD 11.17 billion by FY2031.....Read More

Published on

December 2023

3,300

Purchase Options

USD ($)

arrowdown

i

2,000

i

3,300

i

4,500

i

7,000

Tired of Searching?

Looking for Customization?

Some other doubt?

Need insights from a cohort?

REACH US

    icon_Five
    17, Okhla Industrial Estate Phase 3 Rd, Okhla Phase III, Okhla Industrial Estate, New Delhi, Delhi 110020
    call_Two
    +91 11 42343567
    icon_Six
    info@marketsandata.com
icon_Seven
5741 Cleveland street, Suite 120, VA beach, VA, USA 23462
call_Three
+1 (757) 343-3258
icon_Eight
190 Middle Road, # 14-10 Fortune Centre, Singapore -188979